# Docetaxel

NDC: 43066-044
Generic name: Docetaxel
Labeler / Manufacturer: Baxter Healthcare Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20251127

FDA application: ANDA215744

## Active ingredients

- DOCETAXEL ANHYDROUS: 10 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"43066-044"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=43066-044
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=654319ae-e5f9-4a6a-b566-201923153b6e